CNE100002Y25
CNE100002Y25
NINGBO MENOVO PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.503.122.564 | 1.372.855.273 | 9.5% |
| Cost of Revenue | 976.417.155 | 925.126.995 | 5.5% |
| Gross Profit | 526.705.409 | 447.728.278 | 17.6% |
| 325.999.087 | 302.819.943 | 7.7% | |
| Operating Income | 200.706.322 | 144.908.334 | 38.5% |
| Pretax Income | 129.776.697 | 86.963.729 | 49.2% |
| Net Income Common Stockholders | 102.229.353 | 66.806.624 | 53.0% |
| -- | -- | -- | |
| -- | -- | -- |